These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30222854)

  • 1. Valaciclovir: a culprit drug for drug reaction with eosinophilia and systemic symptoms not to be neglected. Three cases.
    Ingen-Housz-Oro S; Bernier C; Gener G; Fichel F; Barbaud A; Lebrun-Vignes B; Assier H
    Br J Dermatol; 2019 Mar; 180(3):666-667. PubMed ID: 30222854
    [No Abstract]   [Full Text] [Related]  

  • 2. Valacyclovir-induced drug reaction with eosinophilia and systemic symptoms.
    Kitayama S; Makino T; Kataoka K; Mori S; Furukawa F; Torai R; Mizawa M; Shimizu T
    Eur J Dermatol; 2022 Jul; 32(4):538-539. PubMed ID: 36301753
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug Reaction with Eosinophilia and Systemic Symptoms: A Complex Interplay between Drug, T Cells, and Herpesviridae.
    Ganeshanandan L; Lucas M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug Rash with Eosinophilia and Systemic Symptoms syndrome induced by telaprevir in a patient with chronic hepatitis C virus infection].
    Martín Domínguez V; Carrascosa de Lome R; Becerro González I; de Argila D; Villar K; García-Buey L
    Gastroenterol Hepatol; 2015 Oct; 38(8):491-3. PubMed ID: 25454599
    [No Abstract]   [Full Text] [Related]  

  • 5. Reactivation of drug reaction with eosinophilia and systemic symptoms with ranitidine patch testing.
    Teo YX; Ardern-Jones MR
    Contact Dermatitis; 2021 Apr; 84(4):278-279. PubMed ID: 33104238
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug reaction with eosinophilia and systemic symptoms caused by spironolactone: Case report.
    Fernandes RA; Regateiro FS; Faria E; Martinho A; Gonçalo M; Todo-Bom A
    Contact Dermatitis; 2018 Oct; 79(4):255-256. PubMed ID: 30009386
    [No Abstract]   [Full Text] [Related]  

  • 7. Reactivation of Skin Lesions After Patch Testing to Investigate Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome.
    Córdoba S; Navarro-Vidal B; Martínez-Morán C; Borbujo J
    Actas Dermosifiliogr; 2016 Nov; 107(9):781-783. PubMed ID: 27340118
    [No Abstract]   [Full Text] [Related]  

  • 8. First case of drug rash eosinophilia and systemic symptoms due to boceprevir.
    Samain A; Duval-Modeste AB; Joly P; Leblanc C; Massy N; Courville P; Goria O; Riachi G
    J Hepatol; 2014 Apr; 60(4):891-3. PubMed ID: 24333861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of drug reaction with eosinophilia and systemic symptoms induced by ethambutol with early features resembling Stevens-Johnson syndrome.
    Kim JY; Sohn KH; Song WJ; Kang HR
    Acta Derm Venereol; 2013 Nov; 93(6):753-4. PubMed ID: 23584150
    [No Abstract]   [Full Text] [Related]  

  • 10. First case of DRESS syndrome caused by hydroxychloroquine with a positive patch test.
    Castro Jiménez A; Navarrete Navarrete N; Gratacós Gómez AR; Florido López F; García Rodríguez R; Gómez Torrijos E
    Contact Dermatitis; 2021 Jan; 84(1):50-51. PubMed ID: 32654163
    [No Abstract]   [Full Text] [Related]  

  • 11. Captopril-induced DRESS: first reported case confirmed by patch test.
    Chaabane A; Fadhl NB; Chadly Z; Fredj NB; Boughattas NA; Aouam K
    Dermatitis; 2013; 24(5):255-7. PubMed ID: 24030372
    [No Abstract]   [Full Text] [Related]  

  • 12. Pazopanib-Associated Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome: A Case Report.
    Singh P; DʼAngelo RN; Huang V
    Am J Ther; 2019; 26(5):e636-e638. PubMed ID: 30946042
    [No Abstract]   [Full Text] [Related]  

  • 13. DRESS Syndrome Following Levofloxacin Exposure With Positive Patch-test.
    Charfi O; Lakhoua G; Sahnoun R; Badri T; Daghfous R; El Aidli S; Kastalli S; Zaïem A
    Therapie; 2015; 70(6):547-9. PubMed ID: 26238129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of drug rash with eosinophilia and systemic symptoms (DRESS) induced by telaprevir associated with HHV-6 active infection.
    Broccolo F; Ciccarese G; Picciotto A; Drago F
    J Hepatol; 2015 Jan; 62(1):248-9. PubMed ID: 25239077
    [No Abstract]   [Full Text] [Related]  

  • 15. Potassium-paraaminobenzoic acid (Potaba®)-associated DRESS syndrome.
    Viehweg A; Stein A; Bauer A; Spornraft-Ragaller P
    Dermatitis; 2013; 24(5):257-8. PubMed ID: 24045650
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and laboratory improvement after intravenous immunoglobulin in drug reaction with eosinophilia and systemic symptoms.
    Galvão VR; Aun MV; Kalil J; Castells M; Giavina-Bianchi P
    J Allergy Clin Immunol Pract; 2014; 2(1):107-10. PubMed ID: 24565781
    [No Abstract]   [Full Text] [Related]  

  • 17. Allopurinol-induced drug rash with eosinophilia and systemic symptoms mimicking acute generalized exanthematous pustulosis.
    Huang YC; Shih PY; Chin SY; Chiang YY
    J Dermatol; 2012 Dec; 39(12):1077-8. PubMed ID: 22901319
    [No Abstract]   [Full Text] [Related]  

  • 18. A rare and severe cutaneous adverse effect of telaprevir: drug rash with eosinophilia and systemic symptoms.
    Cengiz FP; Su O; Emiroglu N; Biyik Ozkaya D; Bahali AG; Onsun N
    G Ital Dermatol Venereol; 2019 Aug; 154(4):488-491. PubMed ID: 31251007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethoprim-sulfamethoxazole-induced drug reaction with eosinophilia and systemic symptoms in a child with congenital renal disease.
    Maarouf M; Wickenheiser M; Krase JM; Wolter S; Shi VY
    Pediatr Dermatol; 2018 Nov; 35(6):e391-e392. PubMed ID: 30187970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimetazidine, a hitherto unreported cause of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.
    Singh S; Khurana A; Muddebihal A; Jangra M
    Contact Dermatitis; 2021 Mar; 84(3):208-210. PubMed ID: 33034892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.